Relapse remains a determinant of treatment failure and contributes significantly to mortality in acute myeloid leukemia (AML) patients. Despite efforts to understand AML progression and relapse mechanisms. findings on acquired gene mutations in relapse vary. suggesting inherent genetic heterogeneity and emphasizing the role of epigenetic modifications. https://stilleners.shop/product-category/shocks/